Literature DB >> 10233955

Feline leukemia virus long terminal repeat activates collagenase IV gene expression through AP-1.

S K Ghosh1, D V Faller.   

Abstract

Leukemia and lymphoma induced by feline leukemia viruses (FeLVs) are the commonest forms of illness in domestic cats. These viruses do not contain oncogenes, and the source of their pathogenic activity is not clearly understood. Mechanisms involving proto-oncogene activation subsequent to proviral integration and/or development of recombinant viruses with enhanced replication properties are thought to play an important role in their disease pathogenesis. In addition, the long terminal repeat (LTR) regions of these viruses have been shown to be important determinants for pathogenicity and tissue specificity, by virtue of their ability to interact with various transcription factors. Previously, we have shown that, in the case of Moloney murine leukemia virus, the U3 region of the LTR independently induces transcriptional activation of specific cellular genes through an LTR-generated RNA transcript (S. Y. Choi and D. V. Faller, J. Biol. Chem. 269:19691-19694, 1994; S.-Y. Choi and D. V. Faller, J. Virol. 69:7054-7060, 1995). In this report, we show that the U3 region of exogenous FeLV LTRs can induce transcription from collagenase IV (matrix metalloproteinase 9) and monocyte chemotactic protein 1 (MCP-1) promoters up to 12-fold. We also show that AP-1 DNA-binding activity and transcriptional activity are strongly induced in cells expressing FeLV LTRs and that LTR-specific RNA transcripts are generated in those cells. Activation of mitogen-activated protein kinase kinases 1 and 2 (MEK1 and -2) by the LTR is an intermediate step in the FeLV LTR-mediated induction of AP-1 activity. These findings thus suggest that the LTRs of FeLVs can independently activate transcription of specific cellular genes. This LTR-mediated cellular gene transactivation may play an important role in tumorigenesis or preleukemic states and may be a generalizable activity of leukemia-inducing retroviruses.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10233955      PMCID: PMC112537     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  74 in total

1.  The search for physiological substrates of MAP and SAP kinases in mammalian cells.

Authors:  P Cohen
Journal:  Trends Cell Biol       Date:  1997-09       Impact factor: 20.808

2.  Identification of genetic determinants responsible for the rapid immunosuppressive activity and the low leukemogenic potential of a variant of Friend leukemia virus, FIS-2.

Authors:  H Y Dai; G I Troseth; M Gunleksrud; T Bruland; L A Solberg; H Aarset; L I Kristiansen; A Dalen
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

3.  Activation of collagenase IV gene expression and enzymatic activity by the Moloney murine leukemia virus long terminal repeat.

Authors:  D V Faller; H Weng; S Y Choi
Journal:  Virology       Date:  1997-01-20       Impact factor: 3.616

4.  Activation of the human "beta 2-interferon/hepatocyte-stimulating factor/interleukin 6" promoter by cytokines, viruses, and second messenger agonists.

Authors:  A Ray; S B Tatter; L T May; P B Sehgal
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

Review 5.  Endogenous env elements: partners in generation of pathogenic feline leukemia viruses.

Authors:  P Roy-Burman
Journal:  Virus Genes       Date:  1995       Impact factor: 2.332

6.  A 3' end fragment encompassing the transcriptional enhancers of nondefective Friend virus confers erythroleukemogenicity on Moloney leukemia virus.

Authors:  P A Chatis; C A Holland; J E Silver; T N Frederickson; N Hopkins; J W Hartley
Journal:  J Virol       Date:  1984-10       Impact factor: 5.103

7.  Detection of enhancer repeats in the long terminal repeats of feline leukemia viruses from cats with spontaneous neoplastic and nonneoplastic diseases.

Authors:  Y Matsumoto; Y Momoi; T Watari; R Goitsuka; H Tsujimoto; A Hasegawa
Journal:  Virology       Date:  1992-08       Impact factor: 3.616

8.  Constitutively active MAP kinase kinase (MEK1) stimulates SAP kinase and c-Jun transcriptional activity in U937 human leukemic cells.

Authors:  C C Franklin; A S Kraft
Journal:  Oncogene       Date:  1995-12-07       Impact factor: 9.867

9.  Histocompatibility antigens on murine tumors.

Authors:  R S Goodenow; J M Vogel; R L Linsk
Journal:  Science       Date:  1985-11-15       Impact factor: 47.728

10.  Proviral activation of the putative oncogene Pim-1 in MuLV induced T-cell lymphomas.

Authors:  G Selten; H T Cuypers; A Berns
Journal:  EMBO J       Date:  1985-07       Impact factor: 11.598

View more
  7 in total

1.  Long terminal repeat regions from exogenous but not endogenous feline leukemia viruses transactivate cellular gene expression.

Authors:  S K Ghosh; P Roy-Burman; D V Faller
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

2.  Antisense transcription in gammaretroviruses as a mechanism of insertional activation of host genes.

Authors:  Mads Heilskov Rasmussen; Borja Ballarín-González; Jinghua Liu; Louise Berkhoudt Lassen; Annette Füchtbauer; Ernst-Martin Füchtbauer; Anders Lade Nielsen; Finn Skou Pedersen
Journal:  J Virol       Date:  2010-02-03       Impact factor: 5.103

3.  Leukemia virus long terminal repeat activates NFkappaB pathway by a TLR3-dependent mechanism.

Authors:  Ana L Abujamra; Remco A Spanjaard; Idowu Akinsheye; Xiansi Zhao; Douglas V Faller; Sajal K Ghosh
Journal:  Virology       Date:  2005-11-14       Impact factor: 3.616

4.  Oncogene cooperativity in Friend erythroleukemia: erythropoietin receptor activation by the env gene of SFFV leads to transcriptional upregulation of PU.1, independent of SFFV proviral insertion.

Authors:  Iva Afrikanova; Ellen Yeh; David Bartos; Stephanie S Watowich; Gregory D Longmore
Journal:  Oncogene       Date:  2002-02-14       Impact factor: 9.867

5.  Analysis of the disease potential of a recombinant retrovirus containing Friend murine leukemia virus sequences and a unique long terminal repeat from feline leukemia virus.

Authors:  Kazuo Nishigaki; Charlotte Hanson; Delores Thompson; Takashi Yugawa; Masaharu Hisasue; Hajime Tsujimoto; Sandra Ruscetti
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

6.  Identification of LTR-specific small non-coding RNA in FeLV infected cells.

Authors:  Lora W Forman; Ruma Pal-Ghosh; Remco A Spanjaard; Douglas V Faller; Sajal K Ghosh
Journal:  FEBS Lett       Date:  2009-03-29       Impact factor: 4.124

7.  Molecular detection, phylogenetic analysis, and identification of transcription motifs in feline leukemia virus from naturally infected cats in malaysia.

Authors:  Faruku Bande; Siti Suri Arshad; Latiffah Hassan; Zunita Zakaria
Journal:  Vet Med Int       Date:  2014-11-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.